Clinical Trials Browser

Interventional × xentuzumab × Tumor-Agnostic × Clear all

NCT02123823 2025-07-15

BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer

Phase 1 Completed

164 enrolled 21 charts

Neoplasms

NCT01317420 2025-07-11

Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types

Phase 1 Completed

64 enrolled 27 charts

Neoplasms

NCT02145741 2025-06-19

Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours

Phase 1 Completed

21 enrolled 9 charts

Neoplasms